The webinar highlighted exosome technology, led by Andrew Hansford, an expert in aesthetics and hair. Exosomes, once misunderstood, are now seen as key in cellular communication, transporting proteins, lipids, and RNA that influence cell behaviour.

This has significant implications for regenerative medicine, particularly in the fields of hair loss and skin repair. Andrew noted that while stem cells were once the focus, exosomes are now recognised as the main drivers of cellular repair and rejuvenation.

A significant breakthrough discussed was DermapenWorld's patented HLAG component within their exosome technology. This innovative feature is a "game-changer" for regenerative medicine, as it prevents the common "plateauing effect" observed with other exosome treatments. This means DermaperWorld exosomes will continue to work without diminishing effectiveness, offering continuous regenerative support crucial for both long-term skin conditions and sustained hair maintenance.

Furthermore, the webinar revealed the impressive effectiveness of the EXO-GROW range, particularly MG-EXO-GROW and E XO-GROW Tonic. Clinical comparisons have demonstrated that EXO-GROW is 160% more effective than minoxidil, without the negative side effects or toxic chemicals. This marks a significant step forward, offering quicker and more noticeable results.

Corri Marshall, co-founder of DermapenWorld and creator of Dp Dermaceuticals, and Andrew Hansford discussed the profound psychological impact of hair loss. They pointed out that it is not merely a cosmetic issue; it deeply affects self-perception and can lead to significant emotional distress, impacting both men and women across all ages.

The webinar underscored DermapenWorld's commitment to an "honest and upfront approach," emphasising the importance of managing client expectations and providing realistic outcomes from the outset. This empathetic, "hand-holding" approach ensures clients feel supported throughout their hair restoration journey, fostering trust and long-term relationships.

The webinar highlighted the importance of a holistic approach, emphasising that effective home care is as crucial as in-clinic treatments. The EXO-GROW collection is designed to support this synergy, encompassing the entire hair loss journey from scalp health to hair growth and maintenance.

• MG-EXO-GROW (In-Clinic): Designed for use with your Dermapen 4 microneedling device, delivering potent exosome therapy directly to the scalp.

• EXO-GROW Tonic (Home Care): This daily tonic "tricks" the body into maintaining the hair cycle, providing continuous support without side effects. Its efficacy is unmatched, contributing to the 160% improvement over minoxidil.

• EXO-GROW Scalp Mask & Shampoo/Conditioner: These non-negotiable home care products protect the scalp biome, remove impurities, and provide essential nutrients to strengthen and maintain hair integrity.

• EXO-GROW Colour Recharge Shampoo Bar: A fascinating product that uses natural tannins and dark ingredients to gradually repigment hair, offering a permanent colour saturation over time.

• EXO-GROW Lash & Brow: A highly sought-after product offering visible results in as little as four weeks, without irritating ingredients like prostaglandin. It's an excellent entry point for clients to experience the power of exosome technology.

• EXO-SIP&SUPP: An ingestible with marine collagen, B-complexes, and white tomato extract designed to support hair, skin, and overall health from within.

For best results, in-clinic MG-EXO-GROW treatments are recommended every two weeks, with visible changes often after a few sessions. The Dermapen HOME device is essential for clients with hereditary hair loss or extreme thinning. This safe, easy-to-use microneedling device enhances EXO-GROW Tonic absorption, boosting results and allowing clients to participate actively in their maintenance for sustained success.